Target intelligence / Profile preview

L-type voltage-dependent calcium channels (LVDCCs)

Target
LVDCCs
Molecular classification
Voltage-gated calcium channels, Voltage-dependent calcium channels
01

Overview

L-type voltage-dependent calcium channels (LVDCCs) are a class of voltage-gated calcium channels. They have a complex structure composed of five subunits: α1, α2, δ, β, and γ. The α1 subunit is the core functional component containing four homologous domains, each with six transmembrane segments (S1-S6). The S1-S4 segments form the voltage sensing domain, while S5-S6 and the P-loop form the conduction pore and gating apparatus. The α1 subunit has cytosolic N and C termini, with a longer C-terminus. The auxiliary subunits (α2, δ, β, γ) modulate channel function and localization; α2 and δ are extracellular, while β and γ are cytosolic. There are four main subtypes: Cav1.1 (skeletal muscle), Cav1.2 (cardiac and smooth muscle), Cav1.3 (sinoatrial node, various tissues), and Cav1.4 (retinal cells). L-type channels are generally high voltage-activated (except Cav1.3), exhibit slower activation kinetics, rapid deactivation, weak voltage-dependent inactivation, and strong calcium-dependent inactivation. They are highly sensitive to dihydropyridine calcium channel blockers. These channels are essential for excitation-contraction coupling in various muscles, regulation of heart rhythm and development, smooth muscle contraction in blood vessels, aldosterone secretion, and signal transduction during muscle excitation-contraction coupling. The 3D structure, determined by electron cryomicroscopy, shows an asymmetrical heart-shaped and handle-shaped structure, approximately 160 × 220 Å.

Other names
L-type calcium channelsCav1.1Cav1.2Cav1.3Cav1.4
02

Mechanism of action

L-type calcium channels are highly sensitive to and blocked by drugs like dihydropyridine calcium channel blockers, which modulate calcium influx.

03

Biological functions

Excitation-contraction coupling in skeletal, cardiac, and smooth muscleRegulation of heart rhythmNormal heart developmentContraction of smooth muscle cells in blood vesselsAldosterone secretion in endocrine cellsSignal transduction during muscle excitation-contraction coupling
04

Interacting drugs

Dihydropyridine calcium channel blockers

Beyond the preview

Go deeper on L-type voltage-dependent calcium channels (LVDCCs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-type voltage-dependent calcium channels (LVDCCs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call